NMR-spectroscopy-based metabonomic approach to the analysis of Bay41-4109, a novel anti-HBV compound, induced hepatotoxicity in rats.
about
The Need for Biomarkers in Diagnosis and Prognosis of Drug-Induced Liver Disease: Does Metabolomics Have Any Role?Advances in Nuclear Magnetic Resonance for Drug Discovery.Metabolic profiles in serum of mouse after chronic exposure to drinking water.The metabolomic window into hepatobiliary disease.Antiviral activity of Bay 41-4109 on hepatitis B virus in humanized Alb-uPA/SCID miceIn vivo biodistribution and biological impact of injected carbon nanotubes using magnetic resonance techniques.¹H and ³¹P NMR lipidome of ethanol-induced fatty liver.Screening Antitumor Compounds Psoralen and Isopsoralen from Psoralea corylifolia L. Seeds1H-NMR based metabonomic profiling of human esophageal cancer tissue.Preclinical characterization of GLS4, an inhibitor of hepatitis B virus core particle assembly.¹H NMR-based metabolic profiling of human rectal cancer tissueAntihepatitis B therapy: a review of current medications and novel small molecule inhibitors.Hepatitis B: treatment choice and monitoring for response and resistance.Toward Elimination of Hepatitis B Virus Using Novel Drugs, Approaches, and Combined ModalitiesMetabolomic approaches in the discovery of potential urinary biomarkers of drug-induced liver injury (DILI).Effects of psoralen from Psoralea corylifolia on quinone reductase, ornithine decarboxylase, and JB6 cells transformation promotion.Optimised protocols for the metabolic profiling of S. cerevisiae by 1H-NMR and HRMAS spectroscopy.
P2860
Q26772999-C976BD29-6788-4A92-B079-6DCE0F8754F6Q30387229-EF67505E-CF53-4A50-AD1A-2504C83C4B19Q33776529-9FFA101D-5BE2-4286-8FF1-4315BE9F842BQ33893457-F392246C-E869-4B89-8473-4AA25A2B5998Q34097557-11109C8A-7D43-4303-A1E8-C340A9449649Q34788222-8835FE27-20B8-4A5E-826D-F6DC2E1D4A68Q34985548-A9130D7A-5D9D-4B5D-AFBB-827A0D997108Q35102416-2CAE379A-5763-4D11-B1A1-D7A005C6130AQ36766699-A77C2937-2E42-4A9A-BAB1-25E8A716ACADQ37263351-FF1D0083-9BD0-4264-9236-3CD9784DDBDFQ37285687-2DA4D9F9-969C-48F2-9675-587AE9D3C140Q38151881-38E8D867-5CAD-449E-8515-13182AF4021DQ38707903-AF4943B1-6E90-415E-BDB1-6528037EE57CQ38980907-5E535F6E-0A1E-453F-B5DC-0E3A13838D73Q39258217-819FE0B1-C41F-4DF4-8E8D-8D4C9EE645ECQ39563603-FF5DA2D2-A76A-45D1-97D2-5790A8A765AEQ46216789-620922CD-728F-4E00-B7B0-0CE68308BDAB
P2860
NMR-spectroscopy-based metabonomic approach to the analysis of Bay41-4109, a novel anti-HBV compound, induced hepatotoxicity in rats.
description
2007 nî lūn-bûn
@nan
2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
NMR-spectroscopy-based metabon ...... nduced hepatotoxicity in rats.
@ast
NMR-spectroscopy-based metabon ...... nduced hepatotoxicity in rats.
@en
type
label
NMR-spectroscopy-based metabon ...... nduced hepatotoxicity in rats.
@ast
NMR-spectroscopy-based metabon ...... nduced hepatotoxicity in rats.
@en
prefLabel
NMR-spectroscopy-based metabon ...... nduced hepatotoxicity in rats.
@ast
NMR-spectroscopy-based metabon ...... nduced hepatotoxicity in rats.
@en
P2093
P1433
P1476
NMR-spectroscopy-based metabon ...... nduced hepatotoxicity in rats.
@en
P2093
An-Min Cao
Chun-Qi Wu
He-Zhang Sheng
Ming-Yang Liao
Xian-Zhong Yan
P304
P356
10.1016/J.TOXLET.2007.07.010
P577
2007-08-02T00:00:00Z